Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

These 2 Must-Watch Firms Could Get a Boost From Earnings Reports

Two companies reporting earnings in early October could be winners for the upcoming earnings season, based on strong forecasts and notable recent achievements.

MarketBeat

3 Dividend Aristocrats to Buy Before Year’s End

Dividend Aristocrats offer attractive entries at long-term lows: the dividends are reliable, and the share prices are likely to recover.

MarketBeat

Why Semtech Stock Is Rallying After Its NVIDIA Setback

After its NVIDIA-induced cratering, Semtech is up more than 80%. Analysts see more upside to come in this surging chip stock.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

SharkNinja Is Flashing a Buy Signal the Market Is Ignoring

SharkNinja's recent stock decline overlooks its strong earnings, innovation, and significant international growth, creating a clear market disconnect.

MarketBeat

When Downgrades Create Opportunities: 3 Stocks to Watch Now

Analyst downgrades serve as catalysts for buying opportunities in high-quality stocks like Salesforce and Accenture, well-positioned for AI and automation.

MarketBeat

3 REITs to Watch as Rate Cuts Ignite a Real Estate Super Cycle

REITs are standing on several tailwinds now created by recent Fed cuts into high inflation and high asset prices, where property values could rise higher.

MarketBeat

2 Defense Stocks Riding 2025’s Massive Momentum Wave

KTOS and KRMN are two momentum defense stocks with astounding returns in 2025. However, with their forward P/E ratios nearing 150x, warning signs are flashing.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

TrumpRx Brings Pfizer Into the Green—Is It a Buy?

Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy.

MarketBeat

Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal

Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started.

MarketBeat

3 Exceptional Stocks to Build Long-Term Wealth

Discover three standout growth stocks with strong long-term potential, spanning space, retail, and biotech industries, poised for sustained investor returns

MarketBeat

Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?

CoreWeave and Broadcom are bringing in big returns for investors in 2025. However, with insider selling surging, should the future of these names be a concern?

MarketBeat

Marvell Insiders Buy Shares—Should Investors Follow Suit?

Marvell Technology insiders purchased stock after the company announced a buyback plan, affirming a robust outlook for the company's business strength.

MarketBeat

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.

MarketBeat

3 Fintech Stocks That Are Set to Rise as Rates Fall

Fed rate cuts may unlock upside for UPST, AFRM, and RKT stocks, boosting loan volumes, BNPL demand, and mortgage refinancing.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Cleveland-Cliffs Rally Tops S&P 500, Can It Continue?

Cleveland-Cliffs stock is outperforming the S&P 500 by a wide margin this month, driven by several fundamental tailwinds that are set to continue further.

MarketBeat

Joby's Stock Rallies as Public Flights Validate Global Game Plan

Joby Aviation's global flight demonstrations in Japan and the US provide tangible proof of its operational maturity, justifying renewed investor confidence.

MarketBeat

3 Travel Stocks to Watch Heading Into the Holidays

Travel and entertainment spending is expected to increase this holiday season; here are three travel stocks offering opportunities for investors

MarketBeat

Best Stocks Under $15? 3 Low-Priced Picks With Upside

Three companies offer low share prices and strong upside potential, but investors should beware the risks that they carry as well.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Behind D-Wave's Massive Week (And Why Rivals Also Popped)

A sizable rally around the start of October has added to D-Wave's impressive gains so far in 2025, but what's behind the bump? And will it continue?

MarketBeat

Broadcom’s VMware Push Takes Aim at Microsoft, Google, & Amazon

Broadcom's AI chip business is firing on all cylinders. However, its VMware business is moving to take on the likes of MSFT and AMZN, adding upside potential.

MarketBeat

Streaming Shakeout: Which Stocks Could Rebound in Q4?

Streaming stocks face fatigue, but Q4 could bring winners as Netflix, Disney, and Paramount Skydance fight for growth and investor attention

MarketBeat

Get the Best Bang for Your Buck: 3 Low-Cost, High-Return ETFs

Three ETFs capturing unique niche industries each offer a compelling combination of low fees and high returns so far in 2025.

MarketBeat

3 Cybersecurity Stocks Poised for Long-Term Growth

CrowdStrike, Palo Alto, and Fortinet are top cybersecurity stocks, but CrowdStrike’s cloud-native edge makes it the best long-term growth pick

MarketBeat

3 Defense Stocks Surging as Ukraine Tensions Deepen

As the war in Ukraine approaches its fourth year with little progress being made, bullish tailwinds are setting in for European defense contractors.

MarketBeat

Starbucks Stock Slumps; This Competitor Shows Strength

Starbucks is struggling this year, and its new strategic plan looks unlikely to fix its systemic issues. One competitor is offering investors better prospects.

1 … 40 41 42 43

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.